Peter M Andersen
Overview
Explore the profile of Peter M Andersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
228
Citations
9800
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Benatar M, Hansen T, Rom D, Geist M, Blaettler T, Camu W, et al.
Lancet Neurol
. 2024 May;
23(7):687-699.
PMID: 38782015
Background: Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder leading to muscle weakness and respiratory failure. Arimoclomol, a heat-shock protein-70 (HSP70) co-inducer, is neuroprotective in animal models of amyotrophic lateral...
12.
Mutations in the tail and rod domains of the neurofilament heavy-chain gene increase the risk of ALS
Marriott H, Spargo T, Al Khleifat A, Andersen P, Basak N, Cooper-Knock J, et al.
Ann Clin Transl Neurol
. 2024 May;
11(7):1775-1786.
PMID: 38775181
Objective: Neurofilament heavy-chain gene (NEFH) variants are associated with multiple neurodegenerative diseases, however, their relationship with ALS has not been robustly explored. Still, NEFH is commonly included in genetic screening...
13.
Benatar M, Wuu J, Huey E, McMillan C, Petersen R, Postuma R, et al.
Nat Rev Neurol
. 2024 May;
20(6):364-376.
PMID: 38769202
Increasing appreciation of the phenotypic and biological overlap between amyotrophic lateral sclerosis (ALS) and frontotemporal dementia, alongside evolving biomarker evidence for a pre-symptomatic stage of disease and observations that this...
14.
Forsberg K, Karlsborg M, Salvesen L, Svenstrup K, Winroth I, Berntsson H, et al.
Lakartidningen
. 2024 Apr;
121.
PMID: 38666665
We present a patient with familial amyotrophic lateral sclerosis caused by an aggressive A4S mutation in the SOD1 gene. In 2020, the patient was enrolled in the VALOR SOD1 gene...
15.
Van Damme P, Al-Chalabi A, Andersen P, Chio A, Couratier P, de Carvalho M, et al.
Eur J Neurol
. 2024 Mar;
31(6):e16264.
PMID: 38470068
Background: This update of the guideline on the management of amyotrophic lateral sclerosis (ALS) was commissioned by the European Academy of Neurology (EAN) and prepared in collaboration with the European...
16.
Foucher J, Winroth I, Lovik A, Sennfalt S, Pereira J, Fang F, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Jul;
:1-6.
PMID: 37519256
Objective: Cognitive and behavioral impairment is observed in up to 50% of patients with amyotrophic lateral sclerosis (ALS). The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) is a 5-domain screening...
17.
Malmstrom N, Jakobsson Larsson B, Nilsson S, Ohlen J, Nygren I, Andersen P, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Jul;
:1-9.
PMID: 37486108
Aim: The aim of the study was to qualitatively investigate the adolescents' need for professional support when a parent has amyotrophic lateral sclerosis (ALS) - from the adolescents' and the...
18.
Zimyanin V, Pielka A, Glass H, Japtok J, Grossmann D, Martin M, et al.
Cells
. 2023 Jul;
12(10).
PMID: 37408187
Motoneurons are one of the most energy-demanding cell types and a primary target in Amyotrophic lateral sclerosis (ALS), a debilitating and lethal neurodegenerative disorder without currently available effective treatments. Disruption...
19.
Ciecwierska K, Lule D, Bielecki M, Helczyk O, Maksymowicz-Sliwinska A, Finsel J, et al.
BMC Palliat Care
. 2023 Jun;
22(1):72.
PMID: 37312136
Background: Given the inevitable relentless progressing nature of amyotrophic lateral sclerosis (ALS), it is essential to identify factors influencing patients' wellbeing. The study aimed to prospectively assess factors influencing the...
20.
Van Daele S, Moisse M, van Vugt J, Zwamborn R, van der Spek R, van Rheenen W, et al.
Brain
. 2023 Apr;
146(9):3760-3769.
PMID: 37043475
With the advent of gene therapies for amyotrophic lateral sclerosis (ALS), there is a surge in gene testing for this disease. Although there is ample experience with gene testing for...